Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for AV Fistula Maturation in Diabetic ESRD Patients
NCT01863914Phase 2Completed
- Sponsor
- National Cheng Kung University Hospital
- Start
- Nov 2012
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in arteriovenous fistula (AVF) comparing Rosuvastatin with Placebo (2 arms). Primary endpoint: Primary patent rate of AV fistula at 6 months. Started Nov 2012; status: completed.
02
Drugs
rosuvastatin
03
Conditions
arteriovenous fistula (AVF)
Beyond the preview
Go deeper on NCT01863914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01863914.